8.6 Online Preliminary

 Participants

SureMed Technologies Inc

SureMed Technologies (SureMed) targets improving medication safety and efficacy in new area of healthcare by bringing its digital connectivity solutions to injectable medical devices.
SureMed provides pharmaceuticals, healthcare providers and patients the highest quality, and reliable and effective platforms for digitally tracking usage of parenteral drugs using its ePlungers, eCaps and eSleeves, etc in high quality and low cost.
SureMed’s competency is in its disruptive technologies and quality management.

MDX Lifesciences, Inc.

MDX LIFESCIENCES, Inc. is a clinical stage biotechnology company developing
autologous transplantation for tissue and organ regeneration.

Our development programs are primarily focused Myocardial Ischemia, reperfusion injury and neurodegenerative & neuromuscular diseases including: Huntington’s Disease, Multiple Sclerosis/Optic Neuritis, Wolfram Syndrome, Epilepsy, Traumatic Brain Injury (TBI), Duchenne Muscular Dystrophy (DMD), Alzheimer’s Disease, and Parkinson Disease. On-going research has linked these diseases to various malfunctions of the mitochondria. MDX LIFESCIENCES, Inc. aims at opening the way for a broad range of disease modifying therapies for tissue regeneration and achieving clear clinical end points to monitor the various therapies.

Oncoceutics
Oncoceutics is developing a novel class of safe and effective cancer therapies called imipridones. Imipridones have a unique three-ring core structure and selectively target G protein-coupled receptors (GPCRs), the largest class of membrane receptors and a common target of approved drugs that are underexploited in oncology. Despite being historically uncommon as targets in oncology, GPCRs control an array of critical prosurvival and stress signaling pathways that are often dysregulated in human cancer to favor cancer cell survival and propagation.

Aruga Technologies

Aruga is a medical device company that integrates a new nature-inspired, surface technology into the design of synthetic vascular reconstruction devices. Aruga inspired vascular devices are engineered to have a doubled implant lifetime due to their ability to harness nature’s mechanisms and keep blood clot buildup from depositing on the blood contacting surface. Aruga’s TopoGraft have the potential of unparalleled performance and value to patients, surgeons, and hospitals which continue to put emphasis on preferred outcomes at affordable costs.

PhysioCue

PhysioCue, Inc. is a four-year-old consumer digital health and therapy device development company located in the heart of Silicon Valley. PhysioCue devices empower people with high blood pressure to live healthier, happier and longer lives.

We have developed an innovative, non-invasive approach to thermo-neuro-stimulation of the nervous system for immediate and sustainable hypertension reduction therapy management that includes our patented BP Bio-sensor (PPG & ECG) technology.

 

Exact Imaging

Imaging’s ExactVu™ micro-ultrasound platform operates at 29 MHz and enables a whole new level of resolution with the benefits of ease of use, affordability, and is an extension of the current urological workflow. Using the Exact Imaging platform, urologists are able to visualize areas of interest in the prostate and specifically target biopsies at those areas. For those cases where MRI might assist, the FusionVu™ micro-US/MRI fusion application operates on the ExactVu micro-ultrasound platform and facilitates fast, simple MRI fusion-based targeting with the guidance of the micro-ultrasound system’s 70-micron real-time resolution. The ExactVu micro-ultrasound system including the FusionVu application has received regulatory approval in the European Union (CE Mark), the United States (FDA 510(k)), and Canada (Health Canada medical device license).

  Judges

Yun Qin

Investment Director

ZhuHai Institute of Advanced Technology Chinese Academy of Science

Xiaofeng Ren

Founder

Renvigor Biosciences Co.

Wenlong Liu

Top10 Entrepreneurship Tutors of Zhejiang Province

Qianyi Xu

Investment Manager

Huadong Medicine

Zhiyuan Hu

Director

SINOPHARM-CICC

Yonghua Zhou

Chief Scientist

Beijing Huiyu Biomedical Technologies LLC

Kaixuan Liu

Investment Director-Healthcare

Cybernaut(China) Investment